Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05186740 · ClinicalTrials.gov registry record · NA
ProVee Urethral Expander System IDE Study (ProVIDE)
A NA study of Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms, sponsored by ProVerum Medical.
- Active
- Registry status
- NA
- Development phase
- 221
- Enrollment target
- 17
- Study locations
NCT05186740 is a NA study of Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms that is active but no longer recruiting, run by ProVerum Medical. The registered enrollment target is 221 participants. The trial reports 17 study locations across 10 states.
The verdict
NCT05186740, a NA study of Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms, is active but no longer recruiting, sponsored by ProVerum Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 221 participants
- Enrollment target
- 17
- Study locations
Study Summary
A study to evaluate the safety, performance, and effectiveness of the ProVee Urethral Expander System (Investigational Device) when used in subjects with symptomatic urinary obstruction related to benign prostatic hyperplasia (BPH).
Conditions Studied
Interventions
- DEVICE ProVee Urethral Expander System
- PROCEDURE Urethral Access Sheath
Study Locations (17)
Florida
- Urological Research Network Corp - Hialeah
- Advanced Urology Institute - Palm Coast
- Tampa Urology LLC - Tampa
- Avant Concierge Urology - Winter Garden
Texas
- Midtown Urology Assoc. - Austin
- Urology Austin - Austin
- Houston Methodist - Houston
Illinois
- Comprehensive Urologic Care - Lake Barrington
- Southern Illinois University School of Medicine - Springfield
New York
- Mount Sinai - New York
- Manhattan Medical Research Practice - New York
California
- Golden State Urology - Sacramento
Nevada
- Sheldon Freedman MD - Las Vegas
North Carolina
- Associated Urologists of North Carolina - Raleigh
Virginia
- Urology of Virginia - Virginia Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2022-06-09 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05186740
The ClinicalTrials.gov registry entry for NCT05186740 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ProVerum Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms appearing as the primary indexed condition, and to 2 interventions - of which ProVee Urethral Expander System is the first listed.
NCT05186740 reports 17 study locations spanning 10 distinct geographic areas - top geographies include Florida, Texas, Illinois.
Frequently Asked Questions
What is clinical trial NCT05186740 about?
NCT05186740 is a clinical study titled "ProVee Urethral Expander System IDE Study (ProVIDE)". A study to evaluate the safety, performance, and effectiveness of the ProVee Urethral Expander System (Investigational Device) when used in subjects with symptomatic urinary obstruction related to benign prostatic hyperplasia (BPH).
What is the current status of trial NCT05186740?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 221 participants. The study started on 2022-06-09. Estimated completion is 2028-12.
What conditions does trial NCT05186740 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms.
What interventions are being tested in trial NCT05186740?
The interventions under investigation include: ProVee Urethral Expander System (DEVICE), Urethral Access Sheath (PROCEDURE).
Who is sponsoring clinical trial NCT05186740?
This trial is sponsored by ProVerum Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05186740 being conducted?
This trial has 17 study locations across California, Florida, Illinois, Nevada, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.